Hepatitis B is a vaccine-preventable viral disease that involves inflammation of the liver. The hepatitis B virus (HBV) usually leads to a short-term infection known as acute hepatitis B.

Hepatitis B vaccine (recombinant) 10mcg/0.5mL, 20mcg/mL; susp; aluminum hydroxide adsorbed; IM inj; preservative-free. Infection with hepatitis B virus can have serious consequences including ...

Vaccination against HBV began 30 years ago with availability of plasma-derived, inactivated HBsAg vaccines. Soon after, recombinant ... implementation of universal hepatitis vaccination in most ...

In Hepatitis B: The Hunt for a Killer Virus ... in protecting against HBV infection. Although recombinant antigen is used in most vaccines today, the initial proof of principle with a vaccine ...

Discover a clinical trial that was conducted to evaluate the efficacy and safety of autologous HBV vaccine-pulsed dendritic cells and their induced T cells.

Methods: We determined antibody to hepatitis B surface antigen (anti-HBs ... In low risk children initially receiving a recombinant vaccine, 12.5% (26 of 208) and none (0 of 36) retained ...

Interferon Alfa-2B Recombinant, 10 million IU National Museum of American History Recombivax HB, Hepatitis B Vaccine (Recombinant) Pediatric Formulation, 0.5 mL National Museum of American History ...

Hepatitis B surface antigen vaccine (recombinant) 5mcg/0.5mL; susp for IM inj; aluminum hydroxide adsorbed; preservative-free. Ped/Adolescent 5mcg/0.5mL: single-dose vials (yellow cap), single ...

Ab&B Bio-Tech has joined the stacked roster of drug developers queuing up to go public in Hong Kong, filing the paperwork for an IPO to fund development of vaccines that could compete with companies ...

A new study conducted during the first-ever reactive use of the Hecolin vaccine in South Sudan showed that a two-dose regimen ...